 to aspirin in
reducing recurrent ischaemic events in those with diabetes.135 The relative risk reduction was comparable with
those without diabetes, but due to the greater number
of events among people with diabetes, the absolute risk
reduction was even larger. Given the potential beneﬁt, it
is suggested in a Conditional Recommendation that
clopidogrel should be considered as ﬁrst choice, in line
with the aforementioned guidelines.
As an additional alternative to